Journal profile · Pathology
Modern Pathology
ISSN 0893-3952 · eISSN 1530-0285 · Springer Nature · UNITED STATES · Monthly · Founded 2000
Modern Pathology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 6.6; hybrid open access; APC about USD 4,480; median 111 days to acceptance (101 articles, last 24 months); community-reported acceptance: fairly hard; 236 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Modern Pathology is published by Springer Nature and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment and Cancer Genomics and Diagnostics, together about 23.9% of its articles. Its main subfields are Pathology and Forensic Medicine and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the United States and Canadian Academy of PathologyModern Pathology is an international journal owned by the United States & Canadian Academy of Pathology (USCAP). Modern Pathology aims to provide an authoritative platform for publishing the highest quality clinical and translational research studies in pathology.Original manuscripts are the main focus of Modern Pathology. Our scientific communication is enriched by high impact editorials, reviews, and practice guidelines that relate to all aspects of precision diagnostics in human pathology. As such, Modern Pathology's scope encompasses advances in the molecular diagnostics and genomic classifications of disease as well as discoveries in immune-oncology, computational science and applied bioinformatics, and digital pathology.The journal features the following types of papers: Original Articles Review Articles Editorials Long Course Articles
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Rhonda YantissPublisher website
Editorial board by country: 2 in mainland China (about 1%); most named United States 107, Canada 9, France 6, Germany 4, Mainland China 2 (140 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine9.4%
- Lymphoma Diagnosis and TreatmentMedicine7.5%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology7%
- Genetic factors in colorectal cancerMedicine5.9%
- Breast Lesions and CarcinomasMedicine4.6%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.4%
- Ovarian cancer diagnosis and treatmentMedicine4.3%
- Viral-associated cancers and disordersMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pathology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pathology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pathology | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.6LetPub ·
- Impact factor (publisher)
- 6.6Publisher website ·
- CiteScore 2026-06
- 12.5LetPub ·
- CiteScore (publisher)
- 12.5Publisher website ·
- SJR 2026-06
- 2.63LetPub ·
- SNIP 2026-06
- 2.49LetPub ·
- h-index
- 139LetPub ·
- h-index
- 214OpenAlex ·
- i10-index
- 4,500OpenAlex ·
- 2-year mean citedness
- 7.67OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 25.32%LetPub ·
Volume
- Articles per year
- 209LetPub ·
Articles by year OpenAlex count · 6,355 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 133 | 67 | 72 |
| 2025 | 236 | 131 | 1,284 |
| 2024 | 183 | 180 | 2,879 |
| 2023 | 275 | 275 | 5,652 |
| 2022 | 173 | 173 | 3,910 |
| 2021 | 284 | 271 | 9,590 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
111 daysMedian, submission to acceptance · P25–P75 72 days – 161 days
- Acceptance to online
- median 10 days (101 articles)
- Submission to online
- median 124 days
- Sample
- 101 articles with submission and acceptance dates (441 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 29 daysPublisher website ·
- Submission to acceptance
- 120 daysPublisher website ·
- Peer review
- Single anonymous peer review, Open peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,480 / EUR 4,190 / GBP 3,590 / JPY 555,650 | — | — | |
| Publisher website | USD 4,930 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 300 words
- Manuscript length
- ≤ 7,000 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Cover letter
- Required
Article types accepted4, with length limits
- correspondenceOne author is designated the contact author for matters arising from the manuscript (materials requests, technical comments and so on). It is this author's resp…main text ≤ 1,000 words · figures and tables ≤ 2 · references ≤ 10
- editorialEditorials are by invitation only. Interested authors should contact the Editorial Office. No abstract required. Word count should not exceed 1,000. Maximum of …main text ≤ 1,000 words · figures and tables ≤ 2 · references ≤ 10
- research articleResearch Articles must describe in detail a significant advance in human diagnostic pathology. Unstructured abstract, max 300 words. Main body of text (excludin…main text ≤ 7,000 words · abstract ≤ 300 words · figures and tables ≤ 8 · references ≤ 100
- reviewReview Articles require prior approval by the Editor. Review articles must be of general interest to pathologists and contain original, in-depth analysis of the…main text ≤ 5,000 words · abstract ≤ 300 words · figures and tables ≤ 5 · references ≤ 150
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
Each author must have contributed sufficiently to the intellectual content of the submission. The corresponding author should list all authors and their contributions to the work. The corresponding author must confirm that he or she has had full access to the data in the study and final responsibility for the decision to submit for publication.To qualify as a contributing author, one must meet all…
Source ↗Publisher website ·- Conflicts of interest Declaration of Interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- License & copyright Copyright
Copyright: authors complete a Journal Publishing Agreement upon acceptance; gold open access articles use a License Agreement. Model summary
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page from the Journal Homepage for more information.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process; papers deemed suitable are sent to a minimum of two independent expert reviewers; the Editor is responsible for the final decision. Model summary
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprints
Preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 2000
- ISSN
- 0893-3952
- Electronic ISSN
- 1530-0285
- Society / sponsor
- United States and Canadian Academy of Pathology
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Modern Pathology
What CAS zone is Modern Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Modern Pathology is in Zone 1 of Medicine, and in Zone 1 of the minor category Pathology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Modern Pathology?
The latest impact factor listed by LetPub is 6.6; CiteScore 12.5, h-index 214.
How long does peer review take at Modern Pathology?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 111 days (interquartile range 72–161 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Modern Pathology?
According to the journal's author guidelines: Abstract: ≤ 300 words; Manuscript length: ≤ 7,000 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Modern Pathology based?
Of the 140 board members whose country the journal's board page names, 2 (about 1%) are in mainland China; the countries named most often are United States (107), Canada (9) and France (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Modern Pathology?
According to LetPub and DOAJ records, Modern Pathology is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Modern Pathology open access, and what is the APC?
Modern Pathology is a hybrid journal. For open-access publication: APC about USD 4,480.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .